It's not that really. At least not the whole of it. It was just easy to tie him as a face to the kind of corporate entities that people hate. Also his position

It's not that really. At least not the whole of it. It was just easy to tie him as a face to the kind of corporate entities that people hate. Also his position was much more vulnerable than other pharma executives who can afford to pay armies of PR teams, etc. He has a need for attention and a poor sense of self-preservation -- sort of like weev but without being a massive racist.